The Efficacy and Associated Learning Curve of Office-Based High-Resolution Ultrasound to Detect Shell Failure in Breast Implants
Methods/Technique: A retrospective review of in-office PS Imaging HRUS on patients with breast implants was conducted across two plastic surgery practices. Pre-operative ultrasound reports and intra-operative findings reported by the surgeons were compared to determine the accuracy of the initial HRUS reading. Due to the retrospective nature of the study, criteria were established for the HRUS readings in which ambiguous or uncertain terms could be clearly categorized and defined. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for each group of ten subsequent patients to determine test and surgeon accuracy over time. A regression analysis of sensitivity and specificity was completed to determine the learning curve associated with these measures over time.
Results/Complications: Averages for all test values were calculated for the HRUS readings in this study, with overall sensitivity of 77.6%, specificity of 95.1%, positive predictive value of 81.9%, negative predictive value of 93.7%, and overall accuracy of 91.2%. Sensitivity and specificity were then broken down for every group of ten HRUS that were completed, and a regression analysis was performed. The positive predictive value and negative predictive value were not used when looking at the learning curve as these two test measures are based on prevalence. With only two medical practices included in this study and an obviously different prevalence between the two, it was determined that these test measures would not be as useful when determining the learning curve. The regression analysis showed that there was a linear improvement for both sensitivity and specificity over time. The improvement was visible and significant for the sensitivity (p=0.003), and the physicians were able to remain above the standard sensitivity defined by the literature after their 60th HRUS reading. There was also a linear improvement in specificity, but it was not significant (p=0.816). However, it is important to note that the physicians in this study started at a specificity of 100% and their specificity remained above that of the literature standard throughout the course of their HRUS readings.
Conclusion: The results of this study show a high efficacy of HRUS to detect shell failure in silicone breast implants and supports the idea that in-office HRUS is a reliable alternative to MRI for implant surveillance for asymptomatic patients. The test statistics calculated in this study were also higher than previously reported in literature, suggesting recent improvements in equipment and education have improved the efficacy of the HRUS. There is also a calculable linear improvement for all test values of the HRUS as it becomes incorporated into a plastic surgery practice. This improvement shows that continued use and practice with the imaging technique allows for more accurate findings.
